Uravi's profit falls, auditor flags new UK associate
Standalone revenue and profit declined in FY26. The consolidated audit got a modified opinion because the company used unaudited accounts for a new acquisition.
— 1 earlier story on Uravi Defence and Technology Ltd. →What's new
- FY26 standalone net profit fell to ₹1.31 cr from ₹1.78 cr; revenue declined to ₹38.6 cr from ₹41.3 cr.
- Consolidated results carry a modified audit opinion due to reliance on unaudited management accounts for new UK associate Spafax.
- The divestment of problematic subsidiary SKL India was finalized on March 18, 2026.
Why this matters
The modified audit opinion is a technical negative. It means the consolidated numbers aren't fully verified because of the new Spafax acquisition. At least the cleanup of SKL India, a past governance headache, is now complete.
What we're watching
- Audited financials for Spafax, which would clear the modified opinion.
- How Uravi's core defence business performs without SKL India's drag.
- Any further integration costs or governance issues with the Spafax associate.
The full read
Uravi Defence's standalone net profit fell to ₹1.31 crore in FY26 on revenue of ₹38.6 crore, down from ₹1.78 crore and ₹41.3 crore the year before. The numbers themselves are a setback. More concerning is the modified audit opinion on the consolidated results. The auditor couldn't give a clean sign-off because Uravi included the performance of its new UK associate, Spafax, using unaudited management accounts. The standalone report was clean. On the plus side, the company finally closed the sale of its 50.01% stake in SKL India on March 18, 2026. That subsidiary had been a persistent governance headache due to data non-cooperation. Removing it cleans the balance sheet, but the modified opinion on the new acquisition means the consolidated story remains unverified.
Questions answered
- Why did the auditor issue a modified opinion?
- The auditor modified the consolidated report because Uravi used unaudited management accounts to include the results of its new UK associate, Spafax International Holding Ltd. Audited figures for Spafax were not yet available.
- What was the issue with SKL India?
- SKL India had been a source of 'significant data-sharing and reporting disruptions' for Uravi. The company finalized the sale of its 50.01% stake in the subsidiary on March 18, 2026, resolving that governance issue.
- How did the core business perform?
- On a standalone basis, revenue fell 6.5% to ₹38.6 crore and net profit dropped to ₹1.31 crore. The decline suggests pressure on the main defence business even after removing SKL India.
Story so far
All notes on URAVIDEF →- 29 May 2026 · 1:59 PM IST Uravi's profit falls, auditor flags new UK associate
- 1d ago Uravi Defence posts FY26 results. Nothing new here.